Cargando…

Mucosal immunization with a delta-inulin adjuvanted recombinant spike vaccine elicits lung-resident immune memory and protects mice against SARS-CoV-2

Multiple SARS-CoV-2 vaccine candidates have been approved for use and have had a major impact on the COVID-19 pandemic. There remains, however, a significant need for vaccines that are safe, easily transportable and protective against infection, as well as disease. Mucosal vaccination is favored for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stewart, Erica L., Counoupas, Claudio, Johansen, Matt D., Nguyen, Duc H., Miemczyk, Stefan, Hansbro, Nicole G., Ferrell, Kia C., Ashhurst, Anneliese, Alca, Sibel, Ashley, Caroline, Steain, Megan, Britton, Warwick J., Hansbro, Philip M., Petrovsky, Nikolai, Triccas, James A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The authors. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676795/ https://www.ncbi.nlm.nih.gov/pubmed/36411332 http://dx.doi.org/10.1038/s41385-022-00578-9

Ejemplares similares

Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
por: Ferrell, Kia C., et al.
Publicado: (2021)

Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice
por: Ashhurst, Anneliese S., et al.
Publicado: (2022)

Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017)

Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis
por: Counoupas, Claudio, et al.
Publicado: (2020)

Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design
por: Ferrell, Kia C., et al.
Publicado: (2022)

A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection
por: Counoupas, Claudio, et al.
Publicado: (2021)

Characterization of the Protective Immune Responses Conferred by Recombinant BCG Overexpressing Components of Mycobacterium tuberculosis Sec Protein Export System
por: Nisa, Annuurun, et al.
Publicado: (2022)

A unique cytotoxic CD4(+) T cell‐signature defines critical COVID‐19
por: Baird, Sarah, et al.
Publicado: (2023)

No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis
por: Quan, Diana H., et al.
Publicado: (2022)

Advax delta inulin adjuvant overcomes immune immaturity in neonatal mice thereby allowing single–dose influenza vaccine protection
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2015)

Increased SARS-CoV-2 Infection, Protease, and Inflammatory Responses in Chronic Obstructive Pulmonary Disease Primary Bronchial Epithelial Cells Defined with Single-Cell RNA Sequencing
por: Johansen, Matt D., et al.
Publicado: (2022)

Immunotherapy – 2076. A controlled study of delta inulin-adjuvanted honey bee venom immunotherapy
por: Heddle, Robert, et al.
Publicado: (2013)

Randomized controlled trial demonstrating the benefits of delta inulin adjuvanted immunotherapy in patients with bee venom allergy
por: Heddle, Robert, et al.
Publicado: (2019)

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
por: Stewart, Erica, et al.
Publicado: (2019)

L-selectin-dependent and -independent homing of naïve lymphocytes through the lung draining lymph node support T cell response to pulmonary Mycobacterium tuberculosis infection
por: Daniel, Lina, et al.
Publicado: (2023)

Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
por: Petrovsky, Nikolai, et al.
Publicado: (2015)

Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant
por: McPherson, Clifton, et al.
Publicado: (2015)

High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens
por: Counoupas, Claudio, et al.
Publicado: (2022)

Synthesis and Characterization of pH-Sensitive Inulin Conjugate of Isoniazid for Monocyte-Targeted Delivery
por: Afinjuomo, Franklin, et al.
Publicado: (2019)

Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice
por: Counoupas, Claudio, et al.
Publicado: (2016)

Doxorubicin-Loaded Delta Inulin Conjugates for Controlled and Targeted Drug Delivery: Development, Characterization, and In Vitro Evaluation
por: Wang, Lixin, et al.
Publicado: (2019)

Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. Microorganisms 2019, 7, 255
por: Stewart, Erica, et al.
Publicado: (2022)

Novel vaccination approaches to prevent tuberculosis in children
por: Triccas, James A., et al.
Publicado: (2016)

Advax, a Delta Inulin Microparticle, Potentiates In-built Adjuvant Property of Co-administered Vaccines
por: Hayashi, Masayuki, et al.
Publicado: (2016)

Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
por: Gordon, David L., et al.
Publicado: (2016)

Stromal structure remodeling by B lymphocytes limits T cell activation in lymph nodes of Mycobacterium tuberculosis–infected mice
por: Daniel, Lina, et al.
Publicado: (2022)

Safety and immunogenicity of a delta inulin-adjuvanted inactivated Japanese encephalitis virus vaccine in pregnant mares and foals
por: Bielefeldt-Ohmann, Helle, et al.
Publicado: (2014)

P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants
por: Cristillo, AD, et al.
Publicado: (2009)

Immunization strategies to elicit mucosal immune response of HIV
por: Shi, Yinghui
Publicado: (2006)

Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability
por: Burnett, Deborah L., et al.
Publicado: (2021)

Microbiome effects on immunity, health and disease in the lung
por: Shukla, Shakti D, et al.
Publicado: (2017)

Delta Inulin Adjuvant Enhances Plasmablast Generation, Expression of Activation-Induced Cytidine Deaminase and B-Cell Affinity Maturation in Human Subjects Receiving Seasonal Influenza Vaccine
por: Li, Lei, et al.
Publicado: (2015)

Influence of Oxidation Degree on the Physicochemical Properties of Oxidized Inulin
por: Afinjuomo, Franklin, et al.
Publicado: (2020)

The Secreted Lipoprotein, MPT83, of Mycobacterium tuberculosis Is Recognized during Human Tuberculosis and Stimulates Protective Immunity in Mice
por: Kao, Fan F., et al.
Publicado: (2012)

Advax Adjuvant: A Potent and Safe Immunopotentiator Composed of Delta Inulin
por: Petroski, N.
Publicado: (2017)

Molecular Response in Intestinal and Immune Tissues to in Ovo Administration of Inulin and the Combination of Inulin and Lactobacillus lactis Subsp. cremoris
por: Dunislawska, Aleksandra, et al.
Publicado: (2021)

Panblok-H1+advax H1N1/2009pdm vaccine: Insights into rapid development of a delta inulin adjuvanted recombinant pandemic influenza vaccine
por: Honda-Okubo, Yoshikazu, et al.
Publicado: (2017)

Mucosal Barrier and Th2 Immune Responses Are Enhanced by Dietary Inulin in Pigs Infected With Trichuris suis
por: Myhill, Laura J., et al.
Publicado: (2018)

Pulmonary-intestinal cross-talk in mucosal inflammatory disease
por: Keely, Simon, et al.
Publicado: (2011)

CXCR6-Deficiency Improves the Control of Pulmonary Mycobacterium tuberculosis and Influenza Infection Independent of T-Lymphocyte Recruitment to the Lungs
por: Ashhurst, Anneliese S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5i3plb17l4d08uagd92a7uvaiu